Moser Wealth Advisors, LLC Seagen Inc. Transaction History

Moser Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$191.51 - $216.16 $52,665 - $59,444	-275 Reduced 3.96%	6,665 $1.41 Million
Q2 2023 Aug 02, 2023	SELL	$187.64 - $206.25 $28,145 - $30,937	-150 Reduced 2.12%	6,940 $1.34 Million
Q4 2022 Jan 12, 2023	SELL	$117.37 - $139.17 $26,408 - $31,313	-225 Reduced 3.08%	7,090 $911,000
Q2 2022 Aug 02, 2022	SELL	$108.81 - $179.33 $35,363 - $58,282	-325 Reduced 4.25%	7,315 $1.29 Million
Q1 2022 Apr 29, 2022	BUY	$119.61 - $157.85 $19,137 - $25,256	160 Added 2.14%	7,640 $1.1 Million

Q4 2021 Jan 19, 2022	SELL	$142.57 - $190.86 $14,257 - $19,086	-100 Reduced 1.32%	7,480 $1.16 Million
Q3 2021 Oct 18, 2021	BUY	$142.45 - $169.82 $11,680 - $13,925	82 Added 1.09%	7,580 $1.29 Million
Q2 2021 Jul 29, 2021	BUY	$135.08 - $161.1 $16,885 - $20,137	125 Added 1.7%	7,498 $1.18 Million
Q1 2021 May 05, 2021	BUY	$137.51 - $190.8 $140,672 - $195,188	1,023 Added 16.11%	7,373 $1.02 Million
Q4 2020 Jan 29, 2021	BUY	$164.63 - $211.93 $1.05 Million - $1.35 Million	6,350 New	6,350 $1.11 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Moser Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Moser Wealth Advisors, LLC with notifications on news.